telehealth.helpFind my match

Home Weight loss (GLP-1) By state Rhode Island

Rhode Island Medicaid Cut GLP-1 Weight Loss: 8 programs ship to RI

Rhode Island is the newest state on the cut list. Since October 1, 2026, RI Medicaid no longer pays for Wegovy, Zepbound, Saxenda or Foundayo when they're prescribed only for weight loss. If you're in Providence, Warwick or Cranston and just got that letter, here's what's left. The lowest price we found from a program that ships to Rhode Island: compounded semaglutide at $89 a month on a 12-month plan ($99 month to month) at Lttl.

  • Updated
  • Prices read Nov 12, 2026

Rhode Island at a glance

Rhode Island Medicaid
Does not cover for weight loss
State employee plan
Does not cover for weight loss
Adults with obesity
31.3% (2025)
Programs we compare that ship to RI
8 of 22

Online GLP-1 programs for Rhode Island, cheapest first

Programs that ship to Rhode Island. Prescribed online by a licensed clinician; medication and delivery included.

How we pick and check programs

Our pick for November 2026

Daily oral plan
Intro offer: from $7 a day

A daily oral GLP-1 plan. No needles, no injections

GLP-1 protocol from$199/moon the 3-month plan with the $100 welcome credit ($299 without), shipped monthly; the home page names no form for this plan (the oral offer is from $7 a day)
Visit HumeCare Read our HumeCare review

Compounded semaglutide in Rhode Island: lowest monthly price

#ProgramLowest priceMonth to monthLink
1LttlCheapest$89/mo 12-month plan$99 / 4 wksVisitLttl
2BetterMe Rx$99/mo 12-month plan$199/moVisitBetterMe Rx
3Refills$99/mo $99 / 4 wksVisitRefills
4Direct Meds$297/mo $297/moVisitDirect Meds
5GalaFrom $69/mo starting price, plan length not statedNot statedVisitGala
6TrimRxFrom $349/mo starting price, plan length not statedNot statedVisitTrimRx

Compounded tirzepatide in Rhode Island: lowest monthly price

#ProgramLowest priceMonth to monthLink
1MaximusCheapest$99.99/mo 12-month planNot offeredVisitMaximus
2Lttl$139/mo 12-month plan$149 / 4 wksVisitLttl
3BetterMe Rx$159/mo 12-month plan$249/moVisitBetterMe Rx
4Refills$159/mo $159 / 4 wksVisitRefills
5Direct Meds$399/mo $399/moVisitDirect Meds
6GalaFrom $99/mo starting price, plan length not statedNot statedVisitGala
7TrimRxFrom $279/mo starting price, plan length not statedNot statedVisitTrimRx
  1. Low month-to-month#1
    Up to $140 off your first month

    Compounded semaglutide for $99, month to month

    Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month plan
    Visit Lttl Read our Lttl review
  2. Pills or shots#2
    Semaglutide from $99/mo

    Choose weekly shots or daily tablets; shots from $99/mo on the 12-month plan

    Semaglutide shots from$99/moon the 12-month plan; $199 month to month
    Visit BetterMe Rx Read our BetterMe Rx review
  3. No contract#3
    Fall sale: 40% off

    Compounded semaglutide as low as $99 a month

    Semaglutide as low as$99/moper 4-week supply, month to month; shown during a 40% fall sale
    4.2 on Trustpilot1,779 reviews ·
    Visit Refills Read our Refills review
  4. Low-cost tirzepatide#4
    Same price at every dose

    Compounded tirzepatide from $99.99 a month

    Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months
    4.4 on Trustpilot1,106 reviews ·
    Visit Maximus Read our Maximus review
  5. Delivery in 1-2 days#5
    Fall sale: $150 off

    Same price at every dose, at your door in 1-2 days

    Semaglutide$297/momonth to month: medication, doctor visits and shipping included; tirzepatide $399; fall sale: "starting at $147", "$150 off"
    4.5 on Trustpilot17,724 reviews ·
    Visit Direct Meds Read our Direct Meds review

3 more programs are in the price tables above.

October 1, 2026: the Rhode Island Medicaid change in plain words

The cut comes from the state's fiscal year 2027 budget. In an August 2026 memo, the Executive Office of Health and Human Services said four drugs lose coverage when weight loss is the only reason: Foundayo, Saxenda, Wegovy and Zepbound. If a patient needs one of them for another condition, the prescriber has to send a new prior authorization request with the right clinical records. GLP-1s for type 2 diabetes stay covered.

The idea had been public for a year. Rhode Island Current reported in October 2025 that the state was considering ending this coverage. State workers were already in the same spot: the Anchor plans for Rhode Island employees exclude weight-loss drugs unless a plan expressly covers them. Members of Neighborhood Health Plan of Rhode Island's Medicaid plans are covered by the same state rules. Commercial plans in the state set their own policies, so check yours.

So Rhode Islanders who want a GLP-1 for weight and have no coverage for it pay out of pocket. Online programs are a good fit for a small state. You get a video or online visit, and the medication ships to your home. The programs compared here say on their own sites that they ship to Rhode Island. Prices are the same across the state.

  • Under the FY2027 enacted budget, Rhode Island Medicaid stopped covering Foundayo, Saxenda, Wegovy and Zepbound prescribed solely for weight loss on October 1, 2026. (eohhs.ri.gov)
  • For other indications, providers must submit a new prior authorization request with clinical documentation. (eohhs.ri.gov)
  • Rhode Island Current reported in October 2025 that the state was considering ending Medicaid coverage of GLP-1s for weight loss. (rhodeislandcurrent.com)
  • The Rhode Island state employee Anchor plan excludes weight-loss drugs unless expressly covered. (employeebenefits.ri.gov)
  • Rhode Island's adult obesity rate was 31.3% in 2025. (cdc.gov)
  • In a June 25, 2026 statement on Rhode Island's Medicaid change, the American Diabetes Association said obesity costs Rhode Island's economy an estimated $1.7 billion a year. (diabetes.org)
  • In KFF's state table drawn from the CDC's 2025 BRFSS survey, 12.0% of Rhode Island adults had been told they have diabetes (U.S.: 12.5%). (kff.org)
  • CMS runs the Medicare GLP-1 Bridge from July 1, 2026 to December 31, 2027 at a $50 copay; because it sits outside Part D, the copay is not reduced by the low-income subsidy and does not count toward TrOOP. (cms.gov)

Your RI Medicaid GLP-1 refill was denied. Now what?

Start by reading the denial. If the drug was billed only for weight loss, the October 1, 2026 budget change is the reason, and an appeal on the same facts is unlikely to help. If you also have type 2 diabetes, tell your prescriber, because GLP-1s for diabetes are still covered by Rhode Island Medicaid. A diabetes drug would need its own prescription and approval.

If you take Wegovy and have heart disease, ask about the other route the state left open. The state's memo says a prescriber can send a new prior authorization request with clinical records when the drug is needed for something other than weight loss. Wegovy is approved to lower the risk of heart attack and stroke in some adults, so your cardiologist's notes may matter.

If neither fits, plan the switch so there is no long gap. Write down the drug, the dose you were on and the date of your last shot. A clinician in an online program can use that history to choose where to restart. The programs compared on this page say they ship to Rhode Island, and you can see their monthly price before you book a visit.

Rhode Islanders who have both Medicare and Medicaid

People with both Medicare and Medicaid get their prescription drugs through Medicare Part D, not through RI Medicaid. That makes the Medicare GLP-1 Bridge worth checking. It opened on July 1, 2026, sets a $50 monthly copay for certain GLP-1s, and was extended to run until the last day of 2027.

Two rules catch people out. The $50 is paid outside the regular Part D benefit, so it doesn't count toward the yearly out-of-pocket cap. And the low-income subsidy, often called Extra Help, does not reduce it. Even so, $50 a month is far below the cash price of any brand-name GLP-1. Medicare's GLP-1 Bridge page explains how to check whether you qualify.

If you are under 65 and have only Medicaid, the Bridge does not apply. In that case the choice is between proving another covered use, such as type 2 diabetes, or paying cash through a program that ships to the state.

The cost argument behind the cut in a small state

The state framed the change as a budget decision for fiscal year 2027, and the General Assembly kept it in the enacted budget. Health groups pushed back. In a June 25, 2026 statement, the American Diabetes Association said obesity already costs Rhode Island's economy an estimated $1.7 billion a year, and warned that ending coverage could raise rates of diabetes, heart failure and sleep apnea.

The state's own data show what is at stake. Rhode Island's obesity rate, 31.3% of adults in 2025, ranks 36th of the 47 states with CDC figures, so it is lower than most. About 12% of adults have diagnosed diabetes, almost exactly the national share. Both groups will feel the change, since many people with obesity are on the path toward diabetes.

For now there is no bill to restore coverage that we could confirm. Rhode Islanders who want to keep going can pay cash, and the main choice is between compounded and brand-name drugs.

GLP-1 in Rhode Island: questions

Which drugs did Rhode Island Medicaid stop covering on October 1, 2026?

Four drugs, when they're prescribed only for weight loss: Foundayo, Saxenda, Wegovy and Zepbound. The change comes from the state's FY2027 budget. GLP-1s prescribed for type 2 diabetes are still covered. If you were taking one of these for weight and want to continue, the self-pay programs on this page are the simplest way to keep going.

I'm a Neighborhood Health Plan of Rhode Island member. Does this affect me?

If your Neighborhood coverage is through Medicaid, very likely yes. The state's memo applies to Rhode Island Medicaid, and Neighborhood is one of the plans that serves Medicaid members. Call the number on your card to confirm how your plan applies the change. If coverage for weight loss is gone, compare the cash programs listed here.

Can I still get Wegovy through RI Medicaid for a heart condition?

Maybe. The state says that if one of these drugs is medically needed for a reason other than weight loss, your prescriber can send a new prior authorization request with the right clinical records. Wegovy is approved to lower heart attack and stroke risk in some adults. Ask your doctor whether that applies to you.

Do Rhode Island state employees have GLP-1 weight-loss coverage?

Generally no. Ask your plan administrator whether your state employee plan covers weight-loss GLP-1s; we could not read the current plan document. That leaves state workers who want the drugs for weight paying cash. Online programs that ship to Rhode Island list their monthly prices on their own sites. See the comparison above.

What's the cheapest way to stay on a GLP-1 in Rhode Island after losing coverage?

Start by noting which drug and dose you were on and the date of your last dose, so a new clinician can decide where to restart. Compounded tirzepatide or semaglutide from online programs usually costs far less per month than brand-name list prices, especially on longer plans, and some keep one price at every dose. The table on this page lists current prices for programs that ship to Rhode Island.

Does Rhode Island Medicaid still cover Ozempic or Mounjaro for diabetes?

Yes. The October 1, 2026 change applies to Foundayo, Saxenda, Wegovy and Zepbound when they are prescribed only for weight loss. GLP-1s prescribed for type 2 diabetes stay covered. If you have diabetes and lost weight-loss coverage, ask your prescriber whether a diabetes GLP-1 fits your care, since it needs its own approval.

I have Medicare and Medicaid in Rhode Island. Can I get a GLP-1 for $50?

You may. People with both get drugs through Medicare Part D, and the Medicare GLP-1 Bridge charges eligible Part D members $50 a month through December 31, 2027. Extra Help does not lower the $50, and it doesn't count toward your yearly cap. Check eligibility with Medicare or your prescriber.

Can I appeal the Rhode Island Medicaid GLP-1 denial?

You can appeal any denial, but if the drug was prescribed only for weight loss, the budget change itself is the reason, so an appeal is unlikely to win. If you need the drug for another approved use, such as lowering heart risk, your prescriber can send a new prior authorization request with clinical records instead.

Is Rhode Island's Medicaid GLP-1 cut permanent?

It is written into the enacted budget for fiscal year 2027, which runs to June 30, 2027. A later budget could change it, but we found no bill or plan to restore coverage at our check. If you rely on these drugs for weight, it is safer to plan for self-pay than to wait for the rule to reverse.

Can I get a GLP-1 prescribed online in Rhode Island?

Yes. The programs above say on their own sites that they serve Rhode Island.

See programs for Rhode Island All states

Sources: eohhs.ri.gov · cdc.gov · employeebenefits.ri.gov